Follow
Miguel Sanz
Miguel Sanz
Hospital Universitario La Fe
Verified email at uv.es
Title
Cited by
Cited by
Year
Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel
H Döhner, E Estey, D Grimwade, S Amadori, FR Appelbaum, T Büchner, ...
Blood, The Journal of the American Society of Hematology 129 (4), 424-447, 2017
56482017
International scoring system for evaluating prognosis in myelodysplastic syndromes
P Greenberg, C Cox, MM LeBeau, P Fenaux, P Morel, G Sanz, M Sanz, ...
Blood, The Journal of the American Society of Hematology 89 (6), 2079-2088, 1997
55121997
Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet
H Döhner, EH Estey, S Amadori, FR Appelbaum, T Büchner, AK Burnett, ...
Blood, The Journal of the American Society of Hematology 115 (3), 453-474, 2010
42582010
Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group
F Rodeghiero, R Stasi, T Gernsheimer, M Michel, D Provan, DM Arnold, ...
Blood, The Journal of the American Society of Hematology 113 (11), 2386-2393, 2009
32822009
Revised recommendations of the international working group for diagnosis, standardization of response criteria, treatment outcomes, and reporting standards for therapeutic …
BD Cheson, JM Bennett, KJ Kopecky, T Büchner, CL Willman, EH Estey, ...
Journal of clinical oncology 21 (24), 4642-4649, 2003
30072003
International consensus report on the investigation and management of primary immune thrombocytopenia
D Provan, R Stasi, AC Newland, VS Blanchette, P Bolton-Maggs, ...
Blood, The Journal of the American Society of Hematology 115 (2), 168-186, 2010
27052010
Midostaurin plus Chemotherapy for Acute Myeloid Leukemia with a FLT3 Mutation
RM Stone, SJ Mandrekar, BL Sanford, K Laumann, S Geyer, ...
New England Journal of Medicine 377 (5), 454-464, 2017
20972017
Blinatumomab versus chemotherapy for advanced acute lymphoblastic leukemia
H Kantarjian, A Stein, N Gökbuget, AK Fielding, AC Schuh, JM Ribera, ...
New England Journal of Medicine 376 (9), 836-847, 2017
17642017
Management of acute promyelocytic leukemia: recommendations from an expert panel on behalf of the European LeukemiaNet
MA Sanz, D Grimwade, MS Tallman, B Lowenberg, P Fenaux, EH Estey, ...
Blood, The Journal of the American Society of Hematology 113 (9), 1875-1891, 2009
11602009
Efficacy of romiplostim in patients with chronic immune thrombocytopenic purpura: a double-blind randomised controlled trial
DJ Kuter, JB Bussel, RM Lyons, V Pullarkat, TB Gernsheimer, FM Senecal, ...
The Lancet 371 (9610), 395-403, 2008
10782008
A randomized comparison of all transretinoic acid (ATRA) followed by chemotherapy and ATRA plus chemotherapy and the role of maintenance therapy in newly diagnosed acute …
P Fenaux, C Chastang, S Chevret, M Sanz, H Dombret, E Archimbaud, ...
Blood, The Journal of the American Society of Hematology 94 (4), 1192-1200, 1999
9571999
Definition of relapse risk and role of nonanthracycline drugs for consolidation in patients with acute promyelocytic leukemia: a joint study of the PETHEMA and GIMEMA …
MA Sanz, FL Coco, G Martın, G Avvisati, C Rayón, T Barbui, ...
Blood, The Journal of the American Society of Hematology 96 (4), 1247-1253, 2000
8072000
Risk-adapted treatment of acute promyelocytic leukemia with all-trans-retinoic acid and anthracycline monochemotherapy: a multicenter study by the PETHEMA …
MA Sanz, G Martín, M González, A León, C Rayón, C Rivas, D Colomer, ...
Blood 103 (4), 1237-1243, 2004
6072004
A Modified AIDA Protocol With Anthracycline-Based Consolidation Results in High Antileukemic Efficacy and Reduced Toxicity in Newly Diagnosed PML/RAR-Positive Acute …
MA Sanz, G Martı́n, C Rayón, J Esteve, M González, J Dı́az-Mediavilla, ...
Blood, The Journal of the American Society of Hematology 94 (9), 3015-3021, 1999
5381999
Two regression models and a scoring system for predicting survival and planning treatment in myelodysplastic syndromes: a multivariate analysis of prognostic factors in 370 …
GF Sanz, MA Sanz, T Vallespi, MC Canizo, M Torrabadella, S Garcia, ...
5111989
Management of acute promyelocytic leukemia: updated recommendations from an expert panel of the European LeukemiaNet
MA Sanz, P Fenaux, MS Tallman, EH Estey, B Löwenberg, T Naoe, ...
Blood, The Journal of the American Society of Hematology 133 (15), 1630-1643, 2019
5042019
Results from a randomized trial of salvage chemotherapy followed by lestaurtinib for patients with FLT3 mutant AML in first relapse
M Levis, F Ravandi, ES Wang, MR Baer, A Perl, S Coutre, H Erba, ...
Blood, The Journal of the American Society of Hematology 117 (12), 3294-3301, 2011
4522011
Primary plasma cell leukemia: clinical, immunophenotypic, DNA ploidy, and cytogenetic characteristics
R Garcıa-Sanz, A Orfao, M Gonzalez, MD Tabernero, J Bladé, MJ Moro, ...
Blood, The Journal of the American Society of Hematology 93 (3), 1032-1037, 1999
4521999
Incidence, Clinical Features, and Outcome of AllTrans-Retinoic Acid Syndrome in 413 Cases of Newly Diagnosed Acute Promyelocytic Leukemia
S De Botton, H Dombret, M Sanz, JS Miguel, D Caillot, R Zittoun, ...
Blood, The Journal of the American Society of Hematology 92 (8), 2712-2718, 1998
4291998
Causes and prognostic factors of remission induction failure in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and idarubicin
J De La Serna, P Montesinos, E Vellenga, C Rayón, R Parody, A León, ...
Blood, The Journal of the American Society of Hematology 111 (7), 3395-3402, 2008
4212008
The system can't perform the operation now. Try again later.
Articles 1–20